Related Experiment Video
Updated: Jun 2, 2026

Assaying Protein Kinase Activity with Radiolabeled ATP
Published on: May 26, 2017
NMR solution structure of human vaccinia-related kinase 1 (VRK1) reveals the C-terminal tail essential for its
Joon Shin1, Goutam Chakraborty, Nagakumar Bharatham
1School of Biological Sciences, Nanyang Technological University, Singapore 637551.
Abstract:
Vaccinia-related kinase 1 (VRK1) is one of the mitotic kinases that play important roles in cell cycle, nuclear condensation, and transcription regulation. Kinase domain structures of two other VRK family members (VRK2 and VRK3) have been determined previously. However, the structure of VRK1, the most extensively studied and constitutively active VRK member, is yet to be characterized. Here, we present the nuclear magnetic resonance (NMR) solution structure of a catalytically active form of human VRK1 with its extended C-terminal tail (residues 1-361). The NMR structure of human VRK1 reveals that the C-terminal tail orients toward the catalytic site and forms a number of interactions that are critical for structural stability and catalysis. The role of this unique C-terminal tail was further investigated by deletion mutant studies where deletion of the terminal tail resulted in a dramatic reduction in the autocatalytic activity of VRK1. NMR titration studies carried out with ATP or an ATP analog confirm that ATP/ATP analogs interact with all of the crucial residues present in important motifs of the protein kinase such as the hinge region, catalytic loop, DYG motif, and thereby suggest that the catalytic domain of VRK1 is not atypical. In addition to the conventional interactions, some of the residues present on the extended C-terminal tail also interact with the ligands. These observations also substantiate the role of the extended C-terminal tail in the biological activity of VRK1.
Insights
The structure of human Vaccinia-related kinase 1 (VRK1) was determined using NMR, revealing its C-terminal tail is crucial for catalytic activity and stability. Deleting this tail significantly reduced VRK1
Area of Science:
- Biochemistry
- Structural Biology
- Molecular Biology
Background:
- Vaccinia-related kinase 1 (VRK1) is a constitutively active mitotic kinase involved in cell cycle regulation.
- Previous studies determined the structures of VRK2 and VRK3, but VRK1's structure remained uncharacterized.
- VRK1 plays critical roles in nuclear condensation and transcription regulation.
Purpose of the Study:
- To determine the nuclear magnetic resonance (NMR) solution structure of a catalytically active form of human VRK1.
- To elucidate the role of VRK1's extended C-terminal tail in its structural stability and catalytic function.
Main Methods:
- Nuclear Magnetic Resonance (NMR) spectroscopy was used to determine the 3D structure of human VRK1 (residues 1-361).
- Deletion mutant studies were performed to investigate the function of the C-terminal tail.
- NMR titration studies with ATP or ATP analogs were conducted to analyze ligand interactions.
Main Results:
- The NMR structure revealed that the C-terminal tail of VRK1 interacts with the catalytic site, contributing to stability and catalysis.
- Deletion of the C-terminal tail resulted in a significant decrease in VRK1's autocatalytic activity.
- ATP/ATP analog binding studies confirmed interactions with key kinase motifs and also involved residues from the C-terminal tail.
Conclusions:
- The extended C-terminal tail is essential for the structural integrity and catalytic activity of human VRK1.
- The catalytic domain of VRK1, despite the tail's involvement, follows conventional protein kinase architecture.
- These findings highlight the unique regulatory mechanism of VRK1 involving its C-terminal tail.
Related Concept Videos
MAPK Signaling Cascades
Viral Structure
Receptor Tyrosine Kinases
Enzyme-linked Receptors
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...

